ow-density electroencephalography for the assessment and post-treatment evaluation of absence epilepsy seizures

ancaster University0 个研究点目标入组 2 人开始时间: 2018年5月10日最近更新: 2019年12月10日

适应症

试验速览

暂无简介。

•1. Subjects eligible for inclusion in the experimental group for this study are children suspected of having absence seizures between the ages of 3- to 12-years
•2. Subjects eligible for inclusion into the clinical control group are patients of a similar age, referred to Preston for a routine EEG, but not suspected of having absence seizures. If a patient is initially included in the experimental group but gets diagnosed with another condition other than absence seizures, they will be placed in the clinical control group
•3. A further non-clinical control group, also age matched, will be collected at Lancaster University

•1. Confounding medication use:
•1.1. Ritalin
•1.2. Antidepressants
•1.3. Neuroleptic medications
•1.4. Anti-epileptics
•2. Significant learning difficulties, e.g. autism
•3. Neurological conditions, e.g. cerebral palsy
•4. The CI may judge a participant unable to take part in the non-clinical control group if they have a diagnosis of any neurological disorders

发起方

ancaster University